Loading...
Loading...
Contributors:
Dataset URI:
016471f4-b3f4-4129-ba85-61112fb2068eThe main purpose of this study is to evaluate the safety and efficacy of the study drug known as ixekizumab in biologic disease modifying antirheumatic drug (bDMARD) naïve participants with nonradiographic axial spondyloarthritis (nonrad-axSpA).
Keyword(s):
Axial Spondyloarthritis; Endocrinology/Metabolism/Bone; Ixekizumab; Non-radiographic Axial Spondylitis; Placebo.
MeSH Term(s):
Grants and Funding:
Associated Publication(s):
No Associated Publication Data Available
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)